Home/SweetBio/Isaac Rodriguez, PhD
IR

Isaac Rodriguez, PhD

Co-founder, Chief Science Officer

SweetBio

Therapeutic Areas

SweetBio Pipeline

DrugIndicationPhase
VERISDaily wound care (e.g., clinic wounds)Approved
APISChronic and acute wounds (CTP/skin substitute)Approved